INMUNE BIO INC. Dividend, Share-based Payment Arrangement
INMUNE BIO INC. (INMB) reported Dividend, Share-based Payment Arrangement of $7.15 million for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-02.
Discontinued › Shareholders' Equity › Dividend, Share-Based Payment Arrangement
us-gaap:DividendsShareBasedCompensation · last filed 2023-03-02
- INMUNE BIO INC. dividend, share-based payment arrangement for fiscal 2022 was $7.15M, a 49.06% increase from fiscal 2021.
- INMUNE BIO INC. dividend, share-based payment arrangement for fiscal 2021 was $4.80M.
| Period end | Dividend, Share-based Payment Arrangement 12 month |
|---|---|
| 2022-12-31 | $7.15M 10-K · filed 2023-03-02 |
| 2021-12-31 | $4.80M 10-K · filed 2023-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B |